GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Level Bio AB (XSAT:LEVBIO) » Definitions » EV-to-Revenue

Level Bio AB (XSAT:LEVBIO) EV-to-Revenue : 0.68 (As of May. 27, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Level Bio AB EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Level Bio AB's enterprise value is kr15.74 Mil. Level Bio AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was kr23.20 Mil. Therefore, Level Bio AB's EV-to-Revenue for today is 0.68.

The historical rank and industry rank for Level Bio AB's EV-to-Revenue or its related term are showing as below:

XSAT:LEVBIO' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.56   Med: 2.85   Max: 17.22
Current: 0.68

During the past 13 years, the highest EV-to-Revenue of Level Bio AB was 17.22. The lowest was 0.56. And the median was 2.85.

XSAT:LEVBIO's EV-to-Revenue is ranked better than
86.94% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.225 vs XSAT:LEVBIO: 0.68

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Level Bio AB's stock price is kr0.288. Level Bio AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was kr0.36. Therefore, Level Bio AB's PS Ratio for today is 0.79.


Level Bio AB EV-to-Revenue Historical Data

The historical data trend for Level Bio AB's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Bio AB EV-to-Revenue Chart

Level Bio AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.13 2.84 3.59 1.22 0.89

Level Bio AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.34 1.30 1.06 0.89 0.69

Competitive Comparison of Level Bio AB's EV-to-Revenue

For the Diagnostics & Research subindustry, Level Bio AB's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Bio AB's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Level Bio AB's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Level Bio AB's EV-to-Revenue falls into.



Level Bio AB EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Level Bio AB's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=15.736/23.199
=0.68

Level Bio AB's current Enterprise Value is kr15.74 Mil.
Level Bio AB's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr23.20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Bio AB  (XSAT:LEVBIO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Level Bio AB's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.288/0.364
=0.79

Level Bio AB's share price for today is kr0.288.
Level Bio AB's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.36.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Level Bio AB EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Level Bio AB's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Bio AB (XSAT:LEVBIO) Business Description

Traded in Other Exchanges
N/A
Address
Vastra Finnbodavagen 4B, Nacka, Stockholm, SWE, 131 30
AlphaHelix Molecular Diagnostics AB develops, manufactures, and markets products for DNA-identification and quantitation in molecular diagnostics and life science research. Its product inlcude Rob, BugScreener MRSA, and aAmp. The company applications inlcude Diagnostics, PCR and Liquid handling.

Level Bio AB (XSAT:LEVBIO) Headlines

No Headlines